(4-Trifluoromethyl-5,6,7,8-tetrahydroquinazolin-2-yl)thiourea, 98%, 1g

(+/-)-Citronellal>98.0%(GC)100mL

Propylene glycol monobutyl ether, min 99%, for synthesis, 1L, plastic packaging.

3,4-Dibromo-Mal-PEG8-Boc, 100mg

3-Octyl-1H-pyrrole, 98%, 1g

4-Methyl-6-nitroindoline, 95.0%, 1g

(1-(3-Bromophenyl)cyclopropyl)methanol, 98%, 250mg

(R)-4-(2,4-Dimethoxybenzyl)-3-methylpiperazin-2-one, 95.0%, 1g

2-((tert-Butoxycarbonyl)amino)-3-cyclopropylpropanoic acid, 97%, 5g

4-Ethoxy-1,1,1-trifluoro-3-buten-2-one, 96.0%, 5g

4,7-Bis(5-bromo-4-n-octyl-2-thienyl)-2,1,3-benzothiadiazole>97.0%(HPLC)200mg

5-Fluoro-2-nitrobenzamide, 95.0%, 25g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-(tetrahydro-2H-pyran-4-yl)acetic acid, 95%, 500mg